Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
The Bioinformatics Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Diabetologia. 2021 Aug;64(8):1795-1804. doi: 10.1007/s00125-021-05461-z. Epub 2021 Apr 29.
AIMS/HYPOTHESIS: The common muscle-specific TBC1D4 p.Arg684Ter loss-of-function variant defines a subtype of non-autoimmune diabetes in Arctic populations. Homozygous carriers are characterised by elevated postprandial glucose and insulin levels. Because 3.8% of the Greenlandic population are homozygous carriers, it is important to explore possibilities for precision medicine. We aimed to investigate whether physical activity attenuates the effect of this variant on 2 h plasma glucose levels after an oral glucose load.
In a Greenlandic population cohort (n = 2655), 2 h plasma glucose levels were obtained after an OGTT, physical activity was estimated as physical activity energy expenditure and TBC1D4 genotype was determined. We performed TBC1D4-physical activity interaction analysis, applying a linear mixed model to correct for genetic admixture and relatedness.
Physical activity was inversely associated with 2 h plasma glucose levels (β[main effect of physical activity] -0.0033 [mmol/l] / [kJ kg day], p = 6.5 × 10), and significantly more so among homozygous carriers of the TBC1D4 risk variant compared with heterozygous carriers and non-carriers (β[interaction] -0.015 [mmol/l] / [kJ kg day], p = 0.0085). The estimated effect size suggests that 1 h of vigorous physical activity per day (compared with resting) reduces 2 h plasma glucose levels by an additional ~0.7 mmol/l in homozygous carriers of the risk variant.
CONCLUSIONS/INTERPRETATION: Physical activity improves glucose homeostasis particularly in homozygous TBC1D4 risk variant carriers via a skeletal muscle TBC1 domain family member 4-independent pathway. This provides a rationale to implement physical activity as lifestyle precision medicine in Arctic populations.
The Greenlandic Cardio-Metabochip data for the Inuit Health in Transition study has been deposited at the European Genome-phenome Archive ( https://www.ebi.ac.uk/ega/dacs/EGAC00001000736 ) under accession EGAD00010001428.
目的/假设:常见的肌肉特异性 TBC1D4 p.Arg684Ter 失功能变体定义了北极人群中非自身免疫性糖尿病的一个亚型。纯合子携带者的特点是餐后血糖和胰岛素水平升高。由于 3.8%的格陵兰人口是纯合子携带者,因此探索精准医学的可能性非常重要。我们旨在研究体力活动是否能减弱该变体对口服葡萄糖负荷后 2 小时血浆葡萄糖水平的影响。
在格陵兰人群队列(n=2655)中,进行口服葡萄糖耐量试验后测量 2 小时血浆葡萄糖水平,体力活动估计为体力活动能量消耗,TBC1D4 基因型确定。我们进行了 TBC1D4-体力活动相互作用分析,应用线性混合模型校正遗传混合和相关性。
体力活动与 2 小时血浆葡萄糖水平呈负相关(体力活动的主要效应β[mmol/l] / [kJ·kg·天] -0.0033,p=6.5×10),且在 TBC1D4 风险变体的纯合子携带者中与杂合子携带者和非携带者相比更为显著(β[相互作用] -0.015 [mmol/l] / [kJ·kg·天],p=0.0085)。估计的效应大小表明,与休息相比,每天进行 1 小时剧烈体力活动可使风险变体纯合子携带者的 2 小时血浆葡萄糖水平额外降低约 0.7mmol/l。
结论/解释:体力活动通过一种骨骼肌 TBC1 结构域家族成员 4 非依赖性途径改善葡萄糖稳态,特别是在 TBC1D4 风险变体的纯合子携带者中。这为在北极人群中实施体力活动作为生活方式精准医学提供了依据。
因纽特人健康转型研究的格陵兰心脏代谢芯片数据已存入欧洲基因组-表型档案(https://www.ebi.ac.uk/ega/dacs/EGAC00001000736),登录号为 EGAD00010001428。